ADMA Biologics Up Over 24%, on Track for Highest Close Since December 2015 -- Data Talk

Dow Jones05-10

ADMA Biologics, Inc. $(ADMA)$ is currently at $8.62, up $1.70 or 24.46%

 

--Would be highest close since Dec. 14, 2015, when it closed at $8.63

--On pace for largest percent increase since Nov. 10, 2022, when it rose 27.53%

--Currently up two consecutive days; up 25.73% over this period

--Best two day stretch since the two days ending Nov. 11, 2022, when it rose 32.39%

--Up 32.29% month-to-date

--Up 90.82% year-to-date

--Down 31% from its all-time closing high of $12.50 on Nov. 6, 2014

--Up 104.38% from 52 weeks ago (May 12, 2023), when it closed at $4.22

--Would be a new 52-week closing high

--Up 180.03% from its 52-week closing low of $3.08 on Oct. 23, 2023

--Traded as high as $8.74; highest intraday level since April 5, 2016, when it hit $8.80

--Up 26.12% at today's intraday high; largest intraday percent increase since Nov. 10, 2022, when it rose as much as 29.15%

 

All data as of 10:37:05 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

May 10, 2024 10:40 ET (14:40 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment